organization · Reporting owner
Senju Pharmaceutical Co., Ltd.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HYPERION DEFI, INC.EYEN · Entity 7220 | 10% owner | January 29, 2018 | February 09, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HYPERION DEFI, INC.
Report date January 29, 2018 · Filed February 09, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.0001SEC Table I · non-derivative | Direct | 1,718,566 |
Reported balance
After 2018-01-29 transaction · row 1
1 source rowRow 1 · 2018-01-29 · Purchase · Acquired 100,000 · Balance 1,718,566 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2018 Filed Feb 9, 2018 15:25 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | PurchaseCommon Stock, par value $.0001 | 100,000 | $10.00 | $1,000,000.00 |
DisclosureSEC source: 0001144204-18-006799 · tv484959_4.xml · nonDerivative · entry 1 Senju Pharmaceutical Co., Ltd. · CIK 0001728986 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,718,566 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.